Molecular and Cellular Basis of Ulcer Healing

References

• Miller J P, Fargher EB. Relapse of duodenal ulcer: does it matter which drug is used in initial treatment?. Br Med J 1986; 293: 1117–8
   PubMed Web of Science ®Google Scholar
• Ulcer disease: new aspects of pathogenesis and pharmacology, S Szabo, C J Pfeiffer. CRC Press, Boca Raton, FL 1989
   Google Scholar
• Szabo S, Folkman J, Vattay P, Morales R E, Pinkus G S, Kato K. Accelerated healing of duodenal ulcers by oral administration of a mutein of basic fibroblast growth factors in rats. Gastroenterology 1994; 106: 1106–11
   PubMed Web of Science ®Google Scholar
• Szabo S, Folkman J, Vattay P, Morales R E, Kato K. Duodenal ulcerogens: effect of FGF on cysteamine-induced duodenal ulcer. Mechanisms of peptic ulcer healing, F Halter, A Garner, G NJ Tytgat. Kluwer Academic, London 1991; 139–50
   Google Scholar
• Satoh H, Shino A, Murakami I, Asano S, Sato F, Inatomi N. New animal model for gastric ulcer relapse in the rat: bFGF may play a role in prevention of ulcer relapse. Gastroenterology 1992; 102: A159
   Google Scholar
• Stovroff M, Vattay P, Marino B, Szabo S, Folkman J. Healing of experimental gastritis by oral fibroblast growth factor. Surg Forum 1991; 42: 174–5
   Google Scholar
• Lacy E R, Ito S. Rapid epithelial restitution in the gastric mucosa after ethanol injury. Lab Invest 1984; 91: 966–74
   Google Scholar
• Szabo S, Trier J S, Brown A, Schnoor J. Early vascular injury and increased vascular permeability in gastric mucosal injury caused by ethanol in the rat. Gastroenterology 1985; 88: 228–36
   PubMed Web of Science ®Google Scholar
• Leung F W, Robert A, Guth PH. Gastric mucosal blood flow in rats after administration of 16.16-dimethylprostaglandin E2 at a cytoprotective dose. Gastroenterology 1985; 88: 281–9
   PubMed Web of Science ®Google Scholar
• Pihan G, Majzoubi D, Haudenschild C, Trier J S, Szabo S. Early microcirculatory stasis in acute gastric mucosal injury in the rat and prevention by 16.6-dimethyl prostaglandin E2 or sodium thiosulfate. Gastroenterology 1986; 91: 966–74
   PubMed Web of Science ®Google Scholar
• Trier J S, Szabo S, Allan CH. Ethanol-induced damage to mucosal capillaries of rat stomach. Ultrastructural features and effects of prostaglandin F2b and cysteamine. Gastroenterology 1987; 92: 13–22
   PubMedGoogle Scholar
• Carpenter G, Cohen S. Epidermal growth factor. Ann Rev Biochem, 979: 193–216; 48
   Google Scholar
• Gospodarowitz D, Bialecki H. Fibroblasts and epidermal growth factors are mitogenic agents for cultured granulosa cell of rodent, porcine and human origin. Endocrinology 1979; 104: 757–64
   PubMedGoogle Scholar
• Scheving L A, You Y C, Tsai T H, Scheving LE. Circadian phase-dependent stimulatory effect of epidermal growth factor on deoxyribonucleic acid synthesis in the duodenum, jejunum, ileum, coecum, colon and rectum of the adult male mouse. Endocrinology 1980; 106: 1498–503
   PubMed Web of Science ®Google Scholar
• Feldman E J, Aures D, Grossman MI. Epidermal growth factor stimulates ornithine decarboxylase activity in the digestive tract of the mouse. Proc Soc Exp Biol Med 1978; 159: 400–2
   PubMed Web of Science ®Google Scholar
• Elder J B, Williams G, Lacey E, Gregory H. Cellular localization of human urogastrone epidermal growth factor. Nature 1978; 271: 466–7
   PubMed Web of Science ®Google Scholar
• Heitz P U, Kasper M, VanNoorden S V, Polak J M, Gregory H, Pearse A GF. Immunohistochemical localization of urogastrone to human duodenal and submandibular glands. Gut 1978; 19: 408–13
   PubMed Web of Science ®Google Scholar
• Ohmura E, Emoto N, Tsushima T, Watanabe S, Takeuchi T, Kawamura M, et al. Salivary immunoreactive human epidermal growth factor (IR-hEGF) in patients with peptic ulcer disease. Hepatogastroenterology 1987; 34: 160–3
   PubMedGoogle Scholar
• Gospodarowitz D, Bialecki H, Greenburg GJ. Purification of the fibroblast growth factor activity factor from bovine brain. J Biol Chem 1978; 235: 3736–43
   Google Scholar
• Shing Y, Folkman J, Sullivan R, Butterfield C, Murray J, Klagsbrun M. Heparin affinity: purification of a tumor-derived capillary endothelial cell growth factor. Science 1984; 223: 1296–9
   PubMed Web of Science ®Google Scholar
• Renko M, Quarto N, Morimoto T, Rifkin DB. Nuclear and cytoplasmic localization of different basic fibroblast growth factor species. J Cell Physiol 1990; 144: 108–14
   PubMed Web of Science ®Google Scholar
• Florkiewicz R Z, Sommer A. The human bFGF gene encodes four polypeptides: three initiate translation from non-ATG codons. Proc Natl Acad Sci USA 1989; 86: 3978–81
   PubMed Web of Science ®Google Scholar
• Prats H, Kaghad M, Prats A C, Klagsbrun M, Lelias J M, Liauzun P, et al. High molecular mass forms of basic fibroblast growth factor are initiated by alternative CUG codons. Proc Natl Acad Sci USA 1989; 86: 1836–40
   PubMed Web of Science ®Google Scholar
• Sommer A, Moscatelli D, Rifkin DB. An amino terminally extended and post translationally modified form of a 25 kDA basic fibroblast growth factor. Biochem Biophys Res Commun 1989; 160: 1267–74
   PubMedGoogle Scholar
• Klagsbrun M. The fibroblast growth factor family: structural and biological properties. Prog Growth Fact Res 1989; 1: 207–35
   PubMedGoogle Scholar
• Johnsson A, Heldin C H, Wasteson A, Westermark B, Deuel T F, Huang J S, et al. The c-sis gene encodes a precursor of the beta chain of platelet-derived growth factor. EMBO J 1984; 3: 921–8
   PubMed Web of Science ®Google Scholar
• Owen A J, Geyer R P, Antoniades HN. Human platelet-derived growth factor stimulates amino acid transport and protein synthesis by human diploid fibroblast in plasma-free media. Proc Natl Acad Sci USA 1982; 79: 3203–7
   PubMed Web of Science ®Google Scholar
• Mizui T, Doteuchi M. Effects of polyamines on acidified ethanol-induced gastric lesions in rats. Jpn J Pharmacol 1983; 33: 939–45
   PubMedGoogle Scholar
• Konturek S J, Brzozowski T, Dembinski A, Warzecha Z, Yamazaki J. Gastric protective and ulcer-healing action of epidermal growth factor. Advances in drug therapy of gastrointestinal ulceration, A Garner, B Whittle, Jr. John Wiley & Sons, New York 1989; 261–73
   Google Scholar
• Poulsen S S, Olsen K S, Kirkegaard P. Healing of cysteamine-induced duodenal ulcers in the rat. Dig Dis Sci 1985; 30: 161–7
   PubMed Web of Science ®Google Scholar
• Itoh M, Matsuo Y. Epidermal growth factor as a new anti-ulcer drug. J Gastroenterol Hepatol 1994; 9: A14, Suppl 1
   Google Scholar
• Szabo S. The mode of action of sucralfate: the 1×1×1 mechanism of action. Scand J Gastroenterol 1991; 26: 7–12, Suppl 185
   Web of Science ®Google Scholar
• Szabo S, Vattay P, Scarbrough E, Folkman J. Role of vascular factors, including angiogenesis, in the mechanisms of action of sucralfate. Am J Med 1991; 91: 158S–60S, Suppl 2A
   PubMed Web of Science ®Google Scholar
• Folkman J, Szabo S, Stovroff M, McNeil P, Li W, Shing Y. Duodenal ulcer: discovery of a new mechanism and development of angiogenic therapy which accelerates healing. Ann Surg 1991; 214: 414–26
   PubMed Web of Science ®Google Scholar
• Szabo S. Animal model of human disease: duodenal ulcer disease. Animal model: cysteamine-induced acute and chronic duodenal ulcer in the rat. Am J Pathol 1978; 93: 273–6
   PubMed Web of Science ®Google Scholar
• Satoh H, Shino A, Inatomi N, Nagaya H, Sato F, Szabo S, et al. Effects of rhbFGF mutein CS23 (TGP-580) on the healing of gastric ulcers induced by acetic acid in rats. Gastroenterology 1991; 100: A155
   Google Scholar
• Kusstatscher S, Sandor Zs, Satoh H, Szabo S. Inhibition of endogenous basic fibroblast growth factor (bFGF) delays duodenal ulcer healing in rats: implications for a physiologic role of bFGF. Gastroenterology 1994, In press
   Google Scholar
• Dupuy D, Raza A, Szabo S. The role of endogenous nonprotein and protein sulfhydryls in gastic mucosal injury and protection. Ulcer disease: new aspects of pathogenesis and pharmacology, S Szabo, C J Pfeiffer. CRC Press, Boca Raton 1989; 421–34
   Google Scholar
• Szabo S, Trier J S, Brown A, Schnoor J. Sulfhydryl blockers induce severe inflammatory gastritis in the rat. Gastroenterology 1984; 86: 1271
   Google Scholar
• Szabo S, Kusstatscher S, Stovroff M. Role of bFGF and angiogenesis in ulcer healing and the treatment of gastritis. The stomach; physiology, pathophysiology and treatment, W Domschke, S J Konturek. Springer-Verlag, Berlin, Heidelberg, New York, London, Paris, Tokyo, Hong Kong, Barcelona, Budapest 1993; 193–7
   Google Scholar
• Sakoulas G, Kusstatscher S, Ku P T, D'Amore P, Szabo S. Role of endogenous basic fibroblast growth factor in duodenal ulceration. Dig Dis Sci 1993; 38: A11
   Google Scholar
• Kusstatscher S, Bishop J, Brown L, Sandor ZS, Szabo S. Basic fibroblast growth factor (bFGF) immunolocalization in duodenum of normal rats and after duodenal induction. Gastroenterology 1993; 104: A125
   Web of Science ®Google Scholar
• Tarnawski A, Stachura J, Durbin T, Sarfeh I J, Gergely H. Increased expression of epidermal growth factor receptor during gastric ulcer healing in rats. Gastroenterology 1992; 102: 695–8
   PubMed Web of Science ®Google Scholar
• Surrenti C, Milani S, Paladini I, Orsini B, Salvadori G, Calabro A. Role of epidermal growth factor (EGF) in the healing of human gastric ulcer. Dig Dis Sci 1993; 38: A12
   PubMedGoogle Scholar
• Sandor Zs, Kusstatscher S, Karaoli S, Szabo S. Synergistic angiogenesis after joint administration of bFGF and sucralfate in rats. FASEB J 1994; 8: A93
   Google Scholar